[Palliative chemotherapy of head and neck cancer: present status and future development]. [electronic resource]
Producer: 20060428Description: 172-8 p. digitalISSN:- 0935-8943
- Animals
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Deoxycytidine -- administration & dosage
- Disease Progression
- ErbB Receptors -- antagonists & inhibitors
- Forecasting
- Gefitinib
- Head and Neck Neoplasms -- drug therapy
- Humans
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Palliative Care
- Patient Selection
- Protein Kinase Inhibitors -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Quinazolines -- administration & dosage
- Rats
- Taxoids -- administration & dosage
- Time Factors
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.